Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapeutics symbols : Spro save search
Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update
Published: 2024-03-13 (Crawled : 20:00) - globenewswire.com
SPRO | $1.445 2.85% 66K
|
Health Technology
|
| O: 10.24%
H: 3.28%
C: -4.92%
business year update therapeutics results
Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024
Published: 2024-03-06 (Crawled : 13:00) - globenewswire.com
SPRO | $1.445 2.85% 66K
|
Health Technology
|
| O: -0.6%
H: 4.22%
C: 3.61%
report business year update therapeutics financial results
Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections
Published: 2024-02-28 (Crawled : 13:00) - globenewswire.com
SPRO | $1.445 2.85% 66K
|
Health Technology
|
| O: 0.0%
H: 4.27%
C: 1.22%
spr206 treat clearance infections therapeutics
Spero Therapeutics to Present at Cowen’s 44th Annual Healthcare Conference
Published: 2024-02-26 (Crawled : 13:00) - globenewswire.com
SPRO | $1.445 2.85% 66K
|
Health Technology
|
| O: -1.32%
H: 5.37%
C: 0.67%
conference therapeutics
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-01-31 (Crawled : 21:00) - globenewswire.com
SPRO | $1.445 2.85% 66K
|
Health Technology
|
| O: 0.66%
H: 3.27%
C: 2.61%
nasdaq grants therapeutics
Spero Therapeutics Provides Corporate Update and 2024 Outlook
Published: 2024-01-05 (Crawled : 13:00) - globenewswire.com
SPRO | $1.445 2.85% 66K
|
Health Technology
|
| O: 0.0%
H: 2.04%
C: -2.72%
update therapeutics
Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract Infections
Published: 2024-01-02 (Crawled : 13:00) - globenewswire.com
SPRO | $1.445 2.85% 66K
|
Health Technology
|
| O: 0.0%
H: 5.44%
C: 3.4%
first infections therapeutics
Spero Therapeutics Announces Third Quarter 2023 Operating Results and Provides a Business Update
Published: 2023-11-13 (Crawled : 21:00) - globenewswire.com
SPRO | $1.445 2.85% 66K
|
Health Technology
|
| O: 2.7%
H: 7.89%
C: -4.39%
business update therapeutics results
Spero Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results on Monday, November 13, 2023
Published: 2023-11-06 (Crawled : 13:00) - globenewswire.com
SPRO | $1.445 2.85% 66K
|
Health Technology
|
| O: 0.84%
H: 1.67%
C: -3.33%
report business update therapeutics financial results
Spero Therapeutics to Present at Upcoming November Investor Conferences
Published: 2023-11-01 (Crawled : 20:00) - globenewswire.com
SPRO | $1.445 2.85% 66K
|
Health Technology
|
| O: 0.88%
H: 0.87%
C: -0.87%
therapeutics
Spero Therapeutics Appoints Esther Rajavelu as Chief Financial Officer and Chief Business Officer
Published: 2023-11-01 (Crawled : 12:00) - globenewswire.com
SPRO | $1.445 2.85% 66K
|
Health Technology
|
| O: 2.78%
H: 3.6%
C: 2.7%
business therapeutics financial
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-10-31 (Crawled : 20:00) - globenewswire.com
SPRO | $1.445 2.85% 66K
|
Health Technology
|
| O: 2.78%
H: 3.6%
C: 2.7%
nasdaq grants therapeutics
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-09-29 (Crawled : 20:00) - globenewswire.com
SPRO | $1.445 2.85% 66K
|
Health Technology
| Email alert
Add to watchlist
nasdaq grants therapeutics
Spero Therapeutics to Present at Cantor’s Global Healthcare 2023 Investor Conference
Published: 2023-09-20 (Crawled : 20:00) - globenewswire.com
SPRO | $1.445 2.85% 66K
|
Health Technology
|
| O: 0.81%
H: 0.0%
C: -1.61%
conference global therapeutics
Sensorium Therapeutics Appoints Veteran Life Sciences Executive Mr. David Southwell to its Board of Directors
Published: 2023-09-12 (Crawled : 14:30) - biospace.com/
TCRX | News 3 d | $7.175 0.77% 100K
|
Professional, Scientific, and T...
|
| O: -1.92%
H: 7.06%
C: 2.75%
SPRO | $1.445 2.85% 66K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -2.26%
PTCT | News S | $25.72 -0.96% 140K
|
Health Technology
|
| O: -0.47%
H: 1.2%
C: 0.95%
life sciences therapeutics
Spero Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference
Published: 2023-09-06 (Crawled : 12:00) - globenewswire.com
SPRO | $1.445 2.85% 66K
|
Health Technology
|
| O: 0.7%
H: 1.02%
C: -4.17%
conference global therapeutics
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-08-31 (Crawled : 20:00) - globenewswire.com
SPRO | $1.445 2.85% 66K
|
Health Technology
|
| O: 0.67%
H: 2.65%
C: 0.66%
nasdaq grants therapeutics
Spero Therapeutics Announces Second Quarter 2023 Operating Results and Provides a Business Update
Published: 2023-08-10 (Crawled : 20:00) - globenewswire.com
SPRO | $1.445 2.85% 66K
|
Health Technology
|
| O: 1.38%
H: 0.68%
C: -4.76%
business update therapeutics results
Spero Therapeutics to Provide Business Update and Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023
Published: 2023-08-03 (Crawled : 12:00) - globenewswire.com
SPRO | $1.445 2.85% 66K
|
Health Technology
|
| O: 2.28%
H: 0.0%
C: -3.82%
report business update therapeutics financial results
Spero Therapeutics Announces Special Protocol Assessment Agreement with FDA for Phase 3 PIVOT-PO Trial of Tebipenem HBr
Published: 2023-07-31 (Crawled : 12:00) - globenewswire.com
SPRO | $1.445 2.85% 66K
|
Health Technology
|
| O: 9.15%
H: 6.45%
C: 5.16%
fda trial therapeutics agreement
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.64 166.67% 18M
|
AGBA | $2.61 108.8% 41M
|
Finance
CZOO | $9.32 86.77% 18M
|
EDBL | News | $6.7 78.19% 1.7M
|
OPRT | News | $3.37 49.78% 8.9M
|
Finance
MTC | $2.14 37.18% 4.9M
|
Technology Services
VNRX | $0.8 33.33% 2.9M
|
Health Technology
MLEC | $1.79 27.86% 2.6M
|
n/a
PALI | $6.29 27.59% 22M
|
Manufacturing
MCRB | $0.7902 26.51% 6.9M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.